Articles from Hello Heart

Hello Heart, the digital leader in preventive heart health, today released the 2025 Heart Health Matters Report, identifying key trends in how benefit decision-makers are thinking about the human and financial impacts of not only heart disease, but other chronic conditions as well.

Hello Heart, the digital leader in preventive heart health, today announced the appointment of healthcare industry veteran Bill Otten as Commercial President, reporting into Maayan Cohen, CEO and co-founder. He joins the company following another recent key hire, renowned cardiologist Jayne Morgan, MD who joined as VP, Medical Affairs. Together with Hello Heart’s executive team, they aim to advance the company’s mission of improving heart health for millions nationwide.

Hello Heart, the digital leader in preventive heart health, today announced continued expansion into government markets across the United States. Hello Heart’s collaboration with government agencies and public institutions represents a significant step toward making its proven heart health tool accessible to millions of Americans in the comfort of their homes.

A new peer-reviewed study in the Journal of the American Heart Association found that Hello Heart’s digital heart health program was associated with reductions in blood pressure (BP), total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), and weight.

Hello Heart, the digital leader in preventive heart health, today announced results from its latest study observing the benefits of scalable, accessible digital health tools for a growing senior population. Presented at the American College of Cardiology 2024 Conference, study results showed an overwhelming majority of seniors aged 65 and over reduced their blood pressure (BP), cholesterol, and weight over a six month period while managing it with a mobile app, highlighting the potential of mobile technology in the prevention and control of cardiovascular disease (CVD) for the aging population.

Hello Heart, the digital leader in preventive heart health, today released its inaugural Why Heart Health Matters Report, which examines the toll that cardiovascular disease (CVD) takes on employers, health plans, and the people they serve.

Hello Heart, the only digital therapeutic that focuses exclusively on heart health, today announced new data on how minor lifestyle and behavioral changes can have a significant impact on improving heart health.

Hello Heart, the only digital therapeutic that focuses exclusively on heart health, today announced Dot-to-Dot, a new addition to their digital whole heart health program. Dot-to-Dot is a breakthrough feature that leverages well-established clinical research and artificial intelligence (AI) to help people connect their lifestyle choices to their heart health. Something as easy as a short walk or having a conversation with a friend or loved one can help drive sustained blood pressure reduction. While the link between exercise and improved heart health is well-known, not everyone may realize the true impact these simple changes can make to one’s personal health.

Hello Heart, the only digital therapeutic that focuses exclusively on heart health, has released a new study evaluating the program's results for various user population groups in order to demonstrate its effectiveness related to diversity, equity, and inclusion (DEI). The study, published as an abstract in the American Heart Association’s Hypertension journal, indicates that Hello Heart’s hypertension digital coaching program could contribute to health equity, showing similar improvements in heart health for a range of populations, across gender, age, race, and more.

Hello Heart, the only digital therapeutic that focuses exclusively on heart health, today announced a new cholesterol management feature, designed to empower people to improve their heart health. The first-of-its-kind, Hello Heart’s ‘My Cholesterol’ allows users to easily track and understand their cholesterol levels, and provides personalized insights based on peer-reviewed, published recommendations, encouraging them to make positive lifestyle changes to improve their health.

Hello Heart, the only digital therapeutic that focuses on heart health, announced that it has raised $70 million in Series D financing to support significant growth in customer demand.* Growth equity firm Stripes led the round.

Hello Heart, the only digital therapeutics company to focus exclusively on heart disease, is proud to announce it has achieved Validation Institute’s highest validation and credibility certification — Level 1 – Savings. The distinction confirms that Hello Heart’s AI-driven, smartphone-based solution reduced total employer medical spend by an average of $1,865 per participant per year.

CB Insights today named Hello Heart to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world. This year’s Digital Health 150 was unveiled live during CB Insights’ annual Future of Health event.

Hello Heart, the only digital therapeutics company to focus exclusively on heart disease, today announced that its digital health application for blood pressure management can achieve and maintain lower blood pressure over time, even for those most at risk for heart disease. The results, published in JAMA Network Open, a peer-reviewed journal of the American Medical Association, showed that over 84 percent of participants with stage II hypertension achieved a reduction in their systolic blood pressure, which was maintained over three years. This research is the largest multi-year study of the efficacy of a digital therapeutic in controlling hypertension.

Hello Heart, the leader in cardiovascular digital therapeutics, today announced that the company’s application, data storage, and supporting infrastructure has earned Certified status for information security by HITRUST.

Hello Heart, the best-in-class heart health digital therapeutics solution, has completed a $45 million Series C led by IVP. IVP is a top later-stage partner for hypergrowth companies including Coinbase, Lyra Health, Slack, Snap, Twitter, and UiPath, and is one of the strongest growth funds in the world with more than 120 IPOs. Hello Heart’s existing investors, including Khosla Ventures, BlueRun Ventures, Maven Ventures, and Resolute Ventures also participated in the round. In conjunction with the financing, Somesh Dash, General Partner at IVP, will join Hello Heart’s Board of Directors.